Lobe Sciences Ltd. announced that it has expanded its patent portfolio through the filing of international patents in Canada, the United States, Europe and Australia for Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | 0.00% | +25.00% | 0.00% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 3.13M | |
+39.56% | 6.12B | |
-21.20% | 4.19B | |
+10.25% | 3.43B | |
-18.68% | 2.85B | |
-10.17% | 2.31B | |
+46.00% | 1.94B | |
+49.16% | 1.54B | |
-5.91% | 1.55B | |
-18.01% | 1.49B |
- Stock Market
- Equities
- LOBE Stock
- News Lobe Sciences Ltd.
- Lobe Sciences Ltd. Announces the Expansion of Its Patent Portfolio with International Filings